Dr. Martens warned that its performance over the crucial peak trading period, ranging from the year-end holiday season to the post-Christmas clearance sales, will be key to determining full-year results after reporting a weaker-than-expected first half.The British footwear company posted a 9 percent decline in first-half revenues to £290.4 million ...

Your membership benefits:
To continue reading this article REGISTER NOW.